GANX
Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.80 / 10
Underperform
Fundamental analysis reveals subpar strength (2.8/10). Profit-MV and Cash-MV are favorable, but Asset-MV and Revenue-MV are concerning. Key ratios such as PB-ROE (3.4177) place the stock in a higher-risk quartile, while low Inventory and fixed assets turnover ratios suggest inefficiency. Overall, the fundamental picture is challenging, warranting caution.
Analysis Checks(7/10)
Revenue-MV
Value-0.26
Score1/3
Weight12.62%
1M Return5.20%
Value-0.26
Score1/3
Weight12.62%
1M Return5.20%
Gross profit margin (%)
Value36.70
Score1/3
Weight-0.97%
1M Return-0.54%
Value36.70
Score1/3
Weight-0.97%
1M Return-0.54%
PB-ROE
Value3.42
Score2/3
Weight26.52%
1M Return10.68%
Value3.42
Score2/3
Weight26.52%
1M Return10.68%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.61%
1M Return0.86%
Value7979.42
Score3/3
Weight1.61%
1M Return0.86%
Cash-MV
Value-0.07
Score2/3
Weight18.92%
1M Return7.73%
Value-0.07
Score2/3
Weight18.92%
1M Return7.73%
Inventory turnover ratio
Value47.85
Score3/3
Weight11.09%
1M Return5.26%
Value47.85
Score3/3
Weight11.09%
1M Return5.26%
Profit-MV
Value0.46
Score2/3
Weight18.89%
1M Return7.79%
Value0.46
Score2/3
Weight18.89%
1M Return7.79%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.21%
1M Return1.15%
Value1.78
Score2/3
Weight2.21%
1M Return1.15%
Asset-MV
Value-0.50
Score0/3
Weight6.45%
1M Return2.94%
Value-0.50
Score0/3
Weight6.45%
1M Return2.94%
Net profit / Total profit (%)
Value105.33
Score2/3
Weight2.67%
1M Return1.28%
Value105.33
Score2/3
Weight2.67%
1M Return1.28%
Revenue-MV
Value-0.26
Score1/3
Weight12.62%
1M Return5.20%
Value-0.26
Score1/3
Weight12.62%
1M Return5.20%
Inventory turnover ratio
Value47.85
Score3/3
Weight11.09%
1M Return5.26%
Value47.85
Score3/3
Weight11.09%
1M Return5.26%
Gross profit margin (%)
Value36.70
Score1/3
Weight-0.97%
1M Return-0.54%
Value36.70
Score1/3
Weight-0.97%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight18.89%
1M Return7.79%
Value0.46
Score2/3
Weight18.89%
1M Return7.79%
PB-ROE
Value3.42
Score2/3
Weight26.52%
1M Return10.68%
Value3.42
Score2/3
Weight26.52%
1M Return10.68%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.21%
1M Return1.15%
Value1.78
Score2/3
Weight2.21%
1M Return1.15%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.61%
1M Return0.86%
Value7979.42
Score3/3
Weight1.61%
1M Return0.86%
Asset-MV
Value-0.50
Score0/3
Weight6.45%
1M Return2.94%
Value-0.50
Score0/3
Weight6.45%
1M Return2.94%
Cash-MV
Value-0.07
Score2/3
Weight18.92%
1M Return7.73%
Value-0.07
Score2/3
Weight18.92%
1M Return7.73%
Net profit / Total profit (%)
Value105.33
Score2/3
Weight2.67%
1M Return1.28%
Value105.33
Score2/3
Weight2.67%
1M Return1.28%
Is GANX fundamentally strong?
- GANX scores 2.80/10 on fundamentals and holds a Premium valuation at present. Backed by its -235.84% ROE, 0.00% net margin, -3.62 P/E ratio, 11.39 P/B ratio, and 42.99% earnings growth, these metrics solidify its Underperform investment rating.
